12
Participants
Start Date
December 5, 2025
Primary Completion Date
June 30, 2026
Study Completion Date
July 31, 2026
Zafirlukast
Oral zafirlukast is approved to treat asthma and been shown in previous trials to be effective in blocking or mitigating the symptoms of people allergic to cat dander
Allergy & Asthma Medical Group & Research Center
OTHER